Department of Health and Social Care written question – answered am ar 26 Mawrth 2024.
Beth Winter
Llafur, Cwm Cynon
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help ensure adequate availability of (a) atomoxetine, (b) lisdexamfetamine, (c) methylphenidate and (d) other Attention Deficit Hyperactivity Disorder medication within (i) NHS Wales and (ii) Cwm Taf Morgannwg Health Board.
Beth Winter
Llafur, Cwm Cynon
To ask the Secretary of State for Health and Social Care, whether she has had recent discussions with the Welsh Minister for Health and Social Services on the availability of (a) atomoxetine, (b) lisdexamfetamine, (c) methylphenidate and (d) other ADHD medication.
Beth Winter
Llafur, Cwm Cynon
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 15 January 2024 to Question 8042 on Attention Deficit Hyperactivity Disorder: Drugs, whether it remains her Department's policy to resolve disruptions with the supply of ADHD medication by April 2024.
Andrew Stephenson
Assistant Whip, Minister of State (Department of Health and Social Care)
Disruptions to the supply of medicines used for the management of attention deficit hyperactivity disorder (ADHD) have been primarily driven by issues which have resulted in capacity constraints at key manufacturing sites. The Department has been working hard with industry to help resolve those issues and expedite deliveries to boost supplies of medicines uses for the management of ADHD, as quickly as possible. We have been informed that these should largely be resolved by April or May 2024.
As a result of our ongoing activity and intensive work, some issues have been resolved. Certain strengths of lisdexamphetamine, guanfacine, and all strengths of atomoxetine capsules are now available. While supply issues remain for some ADHD medicines, we continue to escalate these issues with manufacturers to ensure action is taken to resolve regulatory issues and expedite deliveries, to alleviate these shortages as soon as possible.
Health is a devolved matter and as such decisions on availability of medicines in Wales are a matter for the devolved administrations. However, the Department works closely with suppliers, NHS England, the Medicines and Healthcare products Regulatory Agency, the devolved administrations, and other stakeholders to ensure patients continue to have access to the treatments they need.
The Department’s officials regularly discuss a range of issues with colleagues in the Welsh Health and Social Services, including on the access to medicines. The Department has had no specific discussions with the Welsh Minister for Health and Social Services.
Yes1 person thinks so
No2 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.
Secretary of State was originally the title given to the two officials who conducted the Royal Correspondence under Elizabeth I. Now it is the title held by some of the more important Government Ministers, for example the Secretary of State for Foreign Affairs.
Ministers make up the Government and almost all are members of the House of Lords or the House of Commons. There are three main types of Minister. Departmental Ministers are in charge of Government Departments. The Government is divided into different Departments which have responsibilities for different areas. For example the Treasury is in charge of Government spending. Departmental Ministers in the Cabinet are generally called 'Secretary of State' but some have special titles such as Chancellor of the Exchequer. Ministers of State and Junior Ministers assist the ministers in charge of the department. They normally have responsibility for a particular area within the department and are sometimes given a title that reflects this - for example Minister of Transport.
